The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

you continuously wear a sensor that sends regular glucose readings to a smartphone app or insulin pump. Medicare Part B should cover several types of CGMs, including the Dexcom G7 or its earlier ...

2 New Dexcom G7 automated insulin delivery and smart insulin pen integrations also announced at ATTD reinforce the company’s status as the most connected CGM brand in the world. 3 During the ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former ...

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across ...